Publications – 2010

  • Martin-Doyle W, Reynolds MR. Is AF Ablation Cost Effective?. J Atr Fibrillation. 2010 Aug 23;3(2):286. doi: 10.4022/jafib.286. eCollection 2010 Aug-Sep.
  • Cannon CP, Stecker EC. New options for stroke prevention in atrial fibrillation. Am J Manag Care. 2010 Nov;16(10 Suppl):S291-7.
  • Cannon CP. An overview of stroke and the impact of atrial fibrillation. Am J Manag Care. 2010 Nov;16(10 Suppl):S273-7.
  • Turchin A, Shubina M, Murphy SN. I am Not Dead Yet: Identification of False-Positive Matches to Death Master File. AMIA Annu Symp Proc. 2010 Nov 13;2010:807-11.
  • Goldberg SI, Shubina M, Niemierko A, Turchin A. A Weighty Problem: Identification, Characteristics and Risk Factors for Errors in EMR Data. AMIA Annu Symp Proc. 2010 Nov 13;2010:251-5.
  • Moscovitch-Lopatin M, Weiss A, Rosas HD, Ritch J, Doros G, Kegel KB, Difiglia M, Kuhn R, Bilbe G, Paganetti P, Hersch S. Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington Disease. PLoS Curr. 2010 Dec 29;2:RRN1205. doi: 10.1371/currents.RRN1205.
  • Gibson CM, Pinto D. Fractional flow reserve: a new set of lenses for the occulostenotic reflex?. JACC Cardiovasc Interv. 2010 Dec;3(12):1282-3. doi: 10.1016/j.jcin.2010.10.004.
  • Mikhail GW, Gerber RT, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Joshi AA, Baim DS, Colombo A. Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the “TAXUS Woman” analysis. JACC Cardiovasc Interv. 2010 Dec;3(12):1250-9. doi: 10.1016/j.jcin.2010.08.020.
  • Mauri L, Massaro JM, Jiang S, Meredith I, Wijns W, Fajadet J, Kandzari DE, Leon MB, Cutlip DE, Thompson KP. Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents. JACC Cardiovasc Interv. 2010 Dec;3(12):1240-9. doi: 10.1016/j.jcin.2010.08.021.
  • Elmariah S, Rajamannan NM. Medical therapy for calcific aortic stenosis: the use of bisphosphonates. Cardiology. 2010;117(3):229-30. doi: 10.1159/000322902. Epub 2011 Jan 4.
  • Sanchorawala V, Seldin DC, Berk JL, Sloan JM, Doros G, Skinner M. Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis. Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):469-72. doi: 10.3816/CLML.2010.n.081.
  • Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J. 2010 Dec;160(6):1149-55. doi: 10.1016/j.ahj.2010.09.004.
  • Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez AF, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). Am Heart J. 2010 Dec;160(6):1130-6, 1136.e1-3. doi: 10.1016/j.ahj.2010.08.041.
  • Mauri L, Kereiakes DJ, Normand SL, Wiviott SD, Cohen DJ, Holmes DR, Bangalore S, Cutlip DE, Pencina M, Massaro JM. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J. 2010 Dec;160(6):1035-41, 1041.e1. doi: 10.1016/j.ahj.2010.07.038.
  • Kereiakes DJ, Cutlip DE, Applegate RJ, Wang J, Yaqub M, Sood P, Su X, Su G, Farhat N, Rizvi A, Simonton CA, Sudhir K, Stone GW. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). J Am Coll Cardiol. 2010 Dec 14;56(25):2084-9. doi: 10.1016/j.jacc.2010.10.006.
  • Acharjee S, Cannon CP. Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidence. Crit Pathw Cardiol. 2010 Dec;9(4):203-6. doi: 10.1097/HPC.0b013e318200f5ea.
  • Pontes HA, Pontes FS, Silva BT, Lima JF, Kato AM, Lameira AG, Silva BS, Pinto DS Jr. A diffuse swelling of the left side of the face. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Dec;110(6):685-90. doi: 10.1016/j.tripleo.2010.08.023.
  • Polak JF, Pencina MJ, Meisner A, Pencina KM, Brown LS, Wolf PA, D’Agostino RB Sr. Associations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotid artery IMT with maximum internal carotid artery IMT. J Ultrasound Med. 2010 Dec;29(12):1759-68. doi: 10.7863/jum.2010.29.12.1759.
  • Schnabel RB, Aspelund T, Li G, Sullivan LM, Suchy-Dicey A, Harris TB, Pencina MJ, D’Agostino RB Sr, Levy D, Kannel WB, Wang TJ, Kronmal RA, Wolf PA, Burke GL, Launer LJ, Vasan RS, Psaty BM, Benjamin EJ, Gudnason V, Heckbert SR. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010 Nov 22;170(21):1909-17. doi: 10.1001/archinternmed.2010.434.
  • Turchin A, Conlin PR. The doctor needs to see you now: accelerating the care of patients with uncontrolled hypertension. Expert Rev Cardiovasc Ther. 2010 Nov;8(11):1501-3. doi: 10.1586/erc.10.140.
  • Kadakia MB, Desai NR, Alexander KP, Chen AY, Foody JM, Cannon CP, Wiviott SD, Scirica BM; National Cardiovascular Data Registry. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry–GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines). JACC Cardiovasc Interv. 2010 Nov;3(11):1166-77. doi: 10.1016/j.jcin.2010.08.015.
  • Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM, Stepanavage M, Liu SX, Gibbons P, Ashraf TB, Zafarino J, Mitchel Y, Barter P; Determining the Efficacy and Tolerability Investigators. Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med. 2010 Dec 16;363(25):2406-15. doi: 10.1056/NEJMoa1009744. Epub 2010 Nov 17.
  • Elmariah S, Delaney JA, O’Brien KD, Budoff MJ, Vogel-Claussen J, Fuster V, Kronmal RA, Halperin JL. Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010 Nov 16;56(21):1752-9. doi: 10.1016/j.jacc.2010.05.050.
  • Kim HN, Januzzi JL Jr. Biomarkers in the management of heart failure. Curr Treat Options Cardiovasc Med. 2010 Dec;12(6):519-31. doi: 10.1007/s11936-010-0096-3.
  • Ormiston JA, Abizaid A, Spertus J, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Dubois C, Hoffmann R, Wijns W, Fitzgerald PJ, Popma JJ, Macours N, Cebrian A, Stoll HP, Rogers C, Spaulding C; NEVO ResElution-I Investigators. Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. Circ Cardiovasc Interv. 2010 Dec;3(6):556-64. doi: 10.1161/CIRCINTERVENTIONS.110.946426. Epub 2010 Nov 9.
  • Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation. 2010 Nov 23;122(21):2131-41. doi: 10.1161/CIRCULATIONAHA.109.927582. Epub 2010 Nov 8.
  • Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP; PROVE IT-TIMI 22 Trial Investigators. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010 Nov 23;122(21):2142-51. doi: 10.1161/CIRCULATIONAHA.109.905687. Epub 2010 Nov 8.
  • Garg P, Charytan DM, Novack L, Cutlip DE, Popma JJ, Moses J, Leon MB, Schofer J, Breithardt G, Schampaert E, Mauri L. Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). Am J Cardiol. 2010 Nov 15;106(10):1436-42. doi: 10.1016/j.amjcard.2010.07.011.
  • Waheed S, Cannon CP. Cardiac rehabilitation. Cardiac rehabilitation reduces the long-term risk of death and cardiovascular complications. Rev Cardiovasc Med. 2010 Summer;11(3):e181-4. doi: 10.3909/ricm0543.
  • Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, Cannon CP, Danchin N, Giusti B, Gurbel P, Horne BD, Hulot JS, Kastrati A, Montalescot G, Neumann FJ, Shen L, Sibbing D, Steg PG, Trenk D, Wiviott SD, Sabatine MS. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010 Oct 27;304(16):1821-30. doi: 10.1001/jama.2010.1543.
  • Dangas GD, George JC, Weintraub W, Popma JJ. Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. JACC Cardiovasc Interv. 2010 Oct;3(10):1096-9. doi: 10.1016/j.jcin.2010.09.005.
  • Leon MB, Nikolsky E, Cutlip DE, Mauri L, Liberman H, Wilson H, Patterson J, Moses J, Kandzari DE; ENDEAVOR IV Investigators. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. JACC Cardiovasc Interv. 2010 Oct;3(10):1043-50. doi: 10.1016/j.jcin.2010.07.008.
  • Natarajan P, Cannon CP. Could direct inhibition of inflammation be the “next big thing” in treating atherosclerosis?. Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2081-3. doi: 10.1161/ATVBAHA.110.213793.
  • Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP. Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients. Aliment Pharmacol Ther. 2010 Nov;32(10):1240-8. doi: 10.1111/j.1365-2036.2010.04465.x. Epub 2010 Sep 23.
  • Weiner RB, Hutter AM Jr, Wang F, Kim J, Weyman AE, Wood MJ, Picard MH, Baggish AL. The impact of endurance exercise training on left ventricular torsion. JACC Cardiovasc Imaging. 2010 Oct;3(10):1001-9. doi: 10.1016/j.jcmg.2010.08.003.
  • Rich JD, Cannon CP, Murphy SA, Qin J, Giugliano RP, Braunwald E. Prior aspirin use and outcomes in acute coronary syndromes. J Am Coll Cardiol. 2010 Oct 19;56(17):1376-85. doi: 10.1016/j.jacc.2010.06.028.
  • Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):615-23. doi: 10.1161/CIRCOUTCOMES.110.957563. Epub 2010 Oct 12.
  • Reynolds MR, Morais E, Zimetbaum P. Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: results from an observational registry. Am Heart J. 2010 Oct;160(4):752-8. doi: 10.1016/j.ahj.2010.06.034.
  • White H, Held C, Stewart R, Watson D, Harrington R, Budaj A, Steg PG, Cannon CP, Krug-Gourley S, Wittes J, Trivedi T, Tarka E, Wallentin L. Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease. Am Heart J. 2010 Oct;160(4):655-61. doi: 10.1016/j.ahj.2010.07.006.
  • Goldberg SI, Niemierko A, Shubina M, Turchin A. “Summary Page”: a novel tool that reduces omitted data in research databases. BMC Med Res Methodol. 2010 Oct 8;10:91. doi: 10.1186/1471-2288-10-91.
  • Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010 Nov 11;363(20):1909-17. doi: 10.1056/NEJMoa1007964. Epub 2010 Oct 6.
  • Januzzi JL Jr, Rehman S, Mueller T, van Kimmenade RR, Lloyd-Jones DM. Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients. Clin Chem. 2010 Dec;56(12):1814-21. doi: 10.1373/clinchem.2010.146506. Epub 2010 Oct 4.
  • Becker RC, Gibson CM, Jennings LK, Morrow DA. Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions. Am J Cardiol. 2010 Oct 15;106(8):S2-3. doi: 10.1016/j.amjcard.2010.08.026.
  • Manzano-Fernández S, Januzzi JL, Boronat-García M, Pastor P, Albaladejo-Otón MD, Garrido IP, Bayes-Genis A, Valdés M, Pascual-Figal DA. Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure. Congest Heart Fail. 2010 Sep-Oct;16(5):214-20. doi: 10.1111/j.1751-7133.2010.00153.x.
  • Dehmer GJ, Douglas JS Jr, Abizaid A, Berg JW, Day J, Hall R, Leon MB, Hijazi ZM, Marchlinski F, Park SJ, Popma JJ; Society for Cardiovascular Angiography and Interventions; American College of Cardiology Foundation; Heart Rhythm Society; European Society of Cardiology; Sociedad Latinoamericana de Cardiología Intervencionista; Asian Pacific Society of Interventional Cardiology; Mended Hearts, Inc. SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future. J Am Coll Cardiol. 2010 Oct 5;56(15):1267-82. doi: 10.1016/j.jacc.2010.08.599.
  • Bayes-Genis A, Pascual-Figal D, Januzzi JL, Maisel A, Casas T, Valdés Chávarri M, Ordóñez-Llanos J. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure. Rev Esp Cardiol. 2010 Oct;63(10):1171-8. doi: 10.1016/s1885-5857(10)70231-0.
  • Dehmer GJ, Douglas JS Jr, Abizaid A, Berg JW, Day J, Hall R, Leon MB, Hijazi ZM, Marchlinski F, Park SJ, Popma JJ. SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings assessments of the past and standards for the future. Heart Rhythm. 2010 Oct;7(10):1522-35. doi: 10.1016/j.hrthm.2010.08.017.
  • Fischell TA, Fischell DR, Avezum A, John MS, Holmes D, Foster M 3rd, Kovach R, Medeiros P, Piegas L, Guimaraes H, Gibson CM. Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemia. J Am Coll Cardiol. 2010 Sep 28;56(14):1089-98. doi: 10.1016/j.jacc.2010.04.053.
  • Dehmer GJ, Douglas JS Jr, Abizaid A, Berg JW, Day J, Hall R, Leon MB, Hijazi ZM, Marchlinski F, Park SJ, Popma JJ; Society for Cardiovascular Angiography and Interventions; American College of Cardiology Foundation; Heart Rhythm Society; European Society of Cardiology; Sociedad Latinoamericana de Cardiologia Intervencionista; Asian-Pacific Society of Interventional Cardiology. SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the Past and Standards for the Future. Catheter Cardiovasc Interv. 2010 Oct 1;76(4):E111-25. doi: 10.1002/ccd.22719.
  • Yeh RW, Yu PB, Drachman DE. Takotsubo cardiomyopathy complicated by cardiac tamponade: classic hemodynamic findings with a new disease. Circulation. 2010 Sep 21;122(12):1239-41. doi: 10.1161/CIRCULATIONAHA.110.955633.
  • Huffman JC, Doughty CT, Januzzi JL, Pirl WF, Smith FA, Fricchione GL. Screening for major depression in post-myocardial infarction patients: operating characteristics of the Beck Depression Inventory-II. Int J Psychiatry Med. 2010;40(2):187-97. doi: 10.2190/PM.40.2.e.
  • Sanchorawala V, Finn KT, Fennessey S, Shelton A, Doros G, Zeldis JB, Seldin DC. Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis. Blood. 2010 Sep 16;116(11):1990-1. doi: 10.1182/blood-2010-07-295485.
  • Vasaiwala S, Forman DE, Mauri L. Drug-eluting stents in the elderly. Curr Treat Options Cardiovasc Med. 2010 Jan;12(1):76-83. doi: 10.1007/s11936-009-0057-x.
  • Henry TD, Gibson CM, Pinto DS. Moving toward improved care for the patient with ST-elevation myocardial infarction: a mandate for systems of care. Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):441-3. doi: 10.1161/CIRCOUTCOMES.110.958421.
  • Storey RF, Angiolillo DJ, Patil SB, Desai B, Ecob R, Husted S, Emanuelsson H, Cannon CP, Becker RC, Wallentin L. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. J Am Coll Cardiol. 2010 Oct 26;56(18):1456-62. doi: 10.1016/j.jacc.2010.03.100.
  • Monaco F, Landoni G, Biselli C, De Luca M, Frau G, Bignami E, Januzzi JL Jr, Zangrillo A. Predictors of cardiac troponin release after mitral valve surgery. J Cardiothorac Vasc Anesth. 2010 Dec;24(6):931-8. doi: 10.1053/j.jvca.2010.06.029. Epub 2010 Sep 15.
  • Goyal A, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Ohman EM, Corbalán R, Eagle KA, Gaxiola E, Gao R, Goto S, D’Agostino RB, Califf RM, Smith SC Jr, Wilson PW; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. Circulation. 2010 Sep 21;122(12):1167-75. doi: 10.1161/CIRCULATIONAHA.109.919274. Epub 2010 Sep 7.
  • Novack V, Nguyen MC, Rooney M, Chacko R, Novack L, Pencina M, Apruzzese P, Mauri L, Cohen SA, Moses J, Leon MB, Cutlip DE. Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents. Am J Cardiol. 2010 Sep 15;106(6):774-9. doi: 10.1016/j.amjcard.2010.04.039. Epub 2010 Aug 2.
  • Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, Wilson PW, Alberts MJ, D’Agostino R, Liau CS, Mas JL, Röther J, Smith SC Jr, Salette G, Contant CF, Massaro JM, Steg PG; REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010 Sep 22;304(12):1350-7. doi: 10.1001/jama.2010.1322. Epub 2010 Aug 30.
  • Bangalore S, Bhatt DL, Röther J, Alberts MJ, Thornton J, Wolski K, Goto S, Hirsch AT, Smith SC, Aichner FT, Topakian R, Cannon CP, Steg PG; REACH Registry Investigators. Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2010 Sep 14;122(11):1091-100. doi: 10.1161/CIRCULATIONAHA.109.933341. Epub 2010 Aug 30.
  • James S, Budaj A, Aylward P, Buck KK, Cannon CP, Cornel JH, Harrington RA, Horrow J, Katus H, Keltai M, Lewis BS, Parikh K, Storey RF, Szummer K, Wojdyla D, Wallentin L. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2010 Sep 14;122(11):1056-67. doi: 10.1161/CIRCULATIONAHA.109.933796. Epub 2010 Aug 30.
  • Acharjee S, Cannon CP. Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers. Crit Pathw Cardiol. 2010 Sep;9(3):156-9. doi: 10.1097/HPC.0b013e3181f00751.
  • Boden WE, Cherr GS, Eagle KA, Cannon CP, Califf RM, Hirsch AT, Alberts MJ, Criqui M, Creager MA, Massaro JM, D’Agostino RB Sr, Steg PG, Bhatt DL; REACH Registry Investigators. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis. Crit Pathw Cardiol. 2010 Sep;9(3):116-25. doi: 10.1097/HPC.0b013e3181e7f93e.
  • Birtcher KK, Pan W, Labresh KA, Cannon CP, Fonarow GC, Ellrodt G. Performance achievement award program for Get With The Guidelines–Coronary Artery Disease is associated with global and sustained improvement in cardiac care for patients hospitalized with an acute myocardial infarction. Crit Pathw Cardiol. 2010 Sep;9(3):103-12. doi: 10.1097/HPC.0b013e3181ed763e.
  • Wolongevicz DM, Zhu L, Pencina MJ, Kimokoti RW, Newby PK, D’Agostino RB, Millen BE. An obesity dietary quality index predicts abdominal obesity in women: potential opportunity for new prevention and treatment paradigms. J Obes. 2010;2010:945987. doi: 10.1155/2010/945987. Epub 2010 Jan 5.
  • Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR; National Cardiovascular Data Registry. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. J Am Coll Cardiol. 2010 Aug 31;56(10):766-73. doi: 10.1016/j.jacc.2010.05.025.
  • Peterson ED, Roe MT, Chen AY, Fonarow GC, Lytle BL, Cannon CP, Rumsfeld JS. The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care. Heart. 2010 Nov;96(22):1798-802. doi: 10.1136/hrt.2010.200261. Epub 2010 Aug 23.
  • McCall WV, Blocker JN, D’Agostino R Jr, Kimball J, Boggs N, Lasater B, Haskett R, Krystal A, McDonald WM, Rosenquist PB. Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression. J Clin Sleep Med. 2010 Aug 15;6(4):322-9.
  • Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, Giugliano R, Braunwald E, Gibson CM; TIMI Study Group. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. JACC Cardiovasc Interv. 2010 Aug;3(8):806-11. doi: 10.1016/j.jcin.2010.05.012.
  • Pride YB, Giuseffi JL, Mohanavelu S, Harrigan CJ, Manning WJ, Gibson CM, Appelbaum E. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct. Am J Cardiol. 2010 Sep 1;106(5):635-40. doi: 10.1016/j.amjcard.2010.04.012.
  • Reynolds MR, Piaskowski SM, Weisgrau KL, Weiler AM, Friedrich TC, Rakasz EG. Ex vivo analysis of SIV-infected cells by flow cytometry. Cytometry A. 2010 Nov;77(11):1059-66. doi: 10.1002/cyto.a.20960.
  • Pencina MJ, D’Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med. 2010 Dec;48(12):1703-11. doi: 10.1515/CCLM.2010.340. Epub 2010 Aug 18.
  • Kumar A, Cannon CP. News and views from the literature. Antiplatelet therapy. Ticagrelor in acute coronary syndrome: a new frontier in platelet inhibition. Rev Cardiovasc Med. 2010 Spring;11(2):117-20.
  • Khera AV, Wolfe ML, Cannon CP, Qin J, Rader DJ. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study). Am J Cardiol. 2010 Aug 15;106(4):451-6. doi: 10.1016/j.amjcard.2010.03.057.
  • Pinnix ZK, Miller LD, Wang W, D’Agostino R Jr, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010 Aug 4;2(43):43ra56. doi: 10.1126/scisignal.3001127.
  • Dhingra R, Gona P, Benjamin EJ, Wang TJ, Aragam J, D’Agostino RB Sr, Kannel WB, Vasan RS. Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail. 2010 Aug;12(8):812-8. doi: 10.1093/eurjhf/hfq106.
  • Lipner RS, Messenger JC, Kangilaski R, Baim DS, Holmes DR Jr, Williams DO, King SB 3rd. A technical and cognitive skills evaluation of performance in interventional cardiology procedures using medical simulation. Simul Healthc. 2010 Apr;5(2):65-74. doi: 10.1097/SIH.0b013e3181c75f8e.
  • Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H, Fiocca L, Matiashvili A, Lortkipanidze N, Vassileva A, Popma JJ, Allocco DJ, Dawkins KD, Valsecchi O, Costa MA. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv. 2010 Aug;3(4):367-75. doi: 10.1161/CIRCINTERVENTIONS.110.950154. Epub 2010 Jul 20.
  • Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. Review of the registry’s fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010 Sep;7(9):1340-5. doi: 10.1016/j.hrthm.2010.07.015. Epub 2010 Jul 18.
  • Cooney MT, Dudina A, D’Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?. Circulation. 2010 Jul 20;122(3):300-10. doi: 10.1161/CIRCULATIONAHA.109.852756.
  • Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, Chen AY, Klein LW, Masoudi FA, McKay C, Hewitt K, Brindis RG, Peterson ED, Rumsfeld JS. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010 Jul 20;56(4):254-63. doi: 10.1016/j.jacc.2010.05.008.
  • O’Connor DS, Elmariah S, Aledort LM, Pinney SP. Disseminated intravascular coagulation complicating Epstein-Barr virus infection in a cardiac transplant recipient: a case report. Transplant Proc. 2010 Jun;42(5):1973-5. doi: 10.1016/j.transproceed.2009.11.044.
  • Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, Mauri L, Kleiman NS, Cohen DJ; EVENT Investigators. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010 Aug;3(4):327-34. doi: 10.1161/CIRCINTERVENTIONS.110.946939. Epub 2010 Jul 6.
  • Olivotto I, Maron BJ, Appelbaum E, Harrigan CJ, Salton C, Gibson CM, Udelson JE, O’Donnell C, Lesser JR, Manning WJ, Maron MS. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Jul 15;106(2):261-7. doi: 10.1016/j.amjcard.2010.03.020.
  • Jeon C, Candia SC, Wang JC, Holper EM, Ammerer M, Kuntz RE, Mauri L. Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: a model for protection from acute myocardial infarction. Am Heart J. 2010 Jul;160(1):195-201. doi: 10.1016/j.ahj.2010.04.004.
  • Leonardi S, Rao SV, Harrington RA, Bhatt DL, Gibson CM, Roe MT, Kochman J, Huber K, Zeymer U, Madan M, Gretler DD, McClure MW, Paynter GE, Thompson V, Welsh RC. Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI). Am Heart J. 2010 Jul;160(1):65-72. doi: 10.1016/j.ahj.2010.04.008.
  • Mauri L, Garg P, Massaro JM, Foster E, Glower D, Mehoudar P, Powell F, Komtebedde J, McDermott E, Feldman T. The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. Am Heart J. 2010 Jul;160(1):23-9. doi: 10.1016/j.ahj.2010.04.009.
  • Palchuk MB, Fang EA, Cygielnik JM, Labreche M, Shubina M, Ramelson HZ, Hamann C, Broverman C, Einbinder JS, Turchin A. An unintended consequence of electronic prescriptions: prevalence and impact of internal discrepancies. J Am Med Inform Assoc. 2010 Jul-Aug;17(4):472-6. doi: 10.1136/jamia.2010.003335.
  • Reynolds MR, Weiler AM, Piaskowski SM, Kolar HL, Hessell AJ, Weiker M, Weisgrau KL, León EJ, Rogers WE, Makowsky R, McDermott AB, Boyle R, Wilson NA, Allison DB, Burton DR, Koff WC, Watkins DI. Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge. J Virol. 2010 Sep;84(18):9190-9. doi: 10.1128/JVI.00041-10. Epub 2010 Jun 30.
  • Huffman JC, Smith FA, Fricchione GL, Januzzi JL, Nadelman S, Pirl WF. Depression and failure of cholesterol lowering after acute myocardial infarction. Prim Care Companion J Clin Psychiatry. 2010;12(1):PCC.08m00766. doi: 10.4088/PCC.08m00766blu.
  • Davidson MH, Beam CA, Haffner S, Perez A, D’Agostino R Sr, Mazzone T. Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study. Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1873-6. doi: 10.1161/ATVBAHA.110.207696. Epub 2010 Jun 24.
  • Gibson CM, Penn DL, Prinstein MJ, Perkins DO, Belger A. Social skill and social cognition in adolescents at genetic risk for psychosis. Schizophr Res. 2010 Sep;122(1-3):179-84. doi: 10.1016/j.schres.2010.04.018. Epub 2010 May 31.
  • Vidovich MI, Vasaiwala S, Cannon CP, Peterson ED, Dai D, Hernandez AF, Fonarow GC; Get With Guidelines Steering Committee and Investigators. Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program. Am Heart J. 2010 Jun;159(6):1026-36. doi: 10.1016/j.ahj.2010.03.013.
  • Sherwood MW, Morrow DA, Scirica BM, Jiang S, Bode C, Rifai N, Gerszten RE, Gibson CM, Cannon CP, Braunwald E, Sabatine MS. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28. Am Heart J. 2010 Jun;159(6):964-971.e1. doi: 10.1016/j.ahj.2010.03.005.
  • Lindsey JB, Cohen DJ, Stolker JM, Meht SK, Mahoney E, Robertus K, House JA, Kennedy K, Riggs L, Rao SV, Marso SP. The impact of bivalirudin on percutaneous coronary intervention-related bleeding. EuroIntervention. 2010 Jun;6(2):206-13.
  • Scirica BM, Morrow DA, Bode C, Ruzyllo W, Ruda M, Oude Ophuis AJ, Lopez-Sendon J, Swedberg K, Ogorek M, Rifai N, Lukashevich V, Maboudian M, Cannon CP, McCabe CH, Braunwald E. Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. Eur Heart J. 2010 Aug;31(16):1993-2005. doi: 10.1093/eurheartj/ehq190. Epub 2010 Jun 17.
  • Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010 Jun 10;362(23):2155-65. doi: 10.1056/NEJMoa0908610.
  • Halpert A, Rybin D, Doros G. Expressive writing is a promising therapeutic modality for the management of IBS: a pilot study. Am J Gastroenterol. 2010 Nov;105(11):2440-8. doi: 10.1038/ajg.2010.246. Epub 2010 Jun 15.
  • Desai SP, Januzzi JL, Pande AN, Pomerantsev EV, Resnic FS, Fossel A, Chibnik LB, Solomon DH. Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention. Semin Arthritis Rheum. 2010 Dec;40(3):215-21. doi: 10.1016/j.semarthrit.2010.04.002. Epub 2010 Jun 11.
  • Dhingra R, Gona P, Wang TJ, Fox CS, D’Agostino RB Sr, Vasan RS. Serum gamma-glutamyl transferase and risk of heart failure in the community. Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1855-60. doi: 10.1161/ATVBAHA.110.207340. Epub 2010 Jun 10.
  • Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail. 2010 Aug;12(8):826-32. doi: 10.1093/eurjhf/hfq091. Epub 2010 Jun 5.
  • Nardulli M, Belviso M, Favia P, d’Agostino R, Gristina R. The study of specific and nonspecific hepatoma cells behavior by means of plasma-treated substrates. J Biomed Mater Res B Appl Biomater. 2010 Jul;94(1):97-107. doi: 10.1002/jbm.b.31629.
  • Cannon CP. Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction. Crit Pathw Cardiol. 2010 Jun;9(2):55-81. doi: 10.1097/HPC.0b013e3181dfd6f8.
  • Hildebrandt P, Collinson PO, Doughty RN, Fuat A, Gaze DC, Gustafsson F, Januzzi J, Rosenberg J, Senior R, Richards M. Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J. 2010 Aug;31(15):1881-9. doi: 10.1093/eurheartj/ehq163. Epub 2010 Jun 2.
  • Marso SP, Amin AP, House JA, Kennedy KF, Spertus JA, Rao SV, Cohen DJ, Messenger JC, Rumsfeld JS; National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010 Jun 2;303(21):2156-64. doi: 10.1001/jama.2010.708.
  • Novack V, Battaglia L, Popma JJ, Cutlip DE. In-hospital and nine-month outcomes among patients with coronary lesions involving a side branch and treated with bare metal stents. Catheter Cardiovasc Interv. 2010 Dec 1;76(7):951-7. doi: 10.1002/ccd.22568.
  • Huffman JC, Celano CM, Januzzi JL. The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes. Neuropsychiatr Dis Treat. 2010 May 6;6:123-36. doi: 10.2147/ndt.s6880.
  • Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 Jul 1;363(1):11-23. doi: 10.1056/NEJMoa0912321. Epub 2010 May 26.
  • Kramer MH, Breydo E, Shubina M, Babcock K, Einbinder JS, Turchin A. Prevalence and factors affecting home blood pressure documentation in routine clinical care: a retrospective study. BMC Health Serv Res. 2010 May 27;10:139. doi: 10.1186/1472-6963-10-139.
  • Turchin A, Goldberg SI, Shubina M, Einbinder JS, Conlin PR. Encounter frequency and blood pressure in hypertensive patients with diabetes mellitus. Hypertension. 2010 Jul;56(1):68-74. doi: 10.1161/HYPERTENSIONAHA.109.148791. Epub 2010 May 24.
  • Truong QA, Garrido-Castro AC, Cannon CP. Patent foramen ovale. Incidental patent foramen ovale during cardiothoracic surgery: to repair or not to repair?. Rev Cardiovasc Med. 2010 Winter;11(1):53-6.
  • Konstantino Y, Zimetbaum PJ, Hsing J, Kramer DB, Chang JD. Cardiac resynchronization therapy for low-flow, low-gradient aortic stenosis. Eur J Heart Fail. 2010 Aug;12(8):889-92. doi: 10.1093/eurjhf/hfq085. Epub 2010 May 21.
  • Shvilkin A, Bojovic B, Vajdic B, Gussak I, Ho KK, Zimetbaum P, Josephson ME. Vectorcardiographic and electrocardiographic criteria to distinguish new and old left bundle branch block. Heart Rhythm. 2010 Aug;7(8):1085-92. doi: 10.1016/j.hrthm.2010.05.024. Epub 2010 May 21.
  • Kereiakes DJ, Cannon LA, Feldman RL, Popma JJ, Magorien R, Whitbourn R, Dauber IM, Rabinowitz AC, Ball MW, Bertolet B, Kabour A, Foster MC, Wang JC, Underwood P, Dawkins KD. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial. J Am Coll Cardiol. 2010 Jul 20;56(4):264-71. doi: 10.1016/j.jacc.2010.04.011. Epub 2010 May 20.
  • Stolker JM, Mahoney EM, Safley DM, Pomposelli FB Jr, Yadav JS, Cohen DJ; SAPPHIRE Investigators. Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at HIgh Risk for Endarterectomy) trial. JACC Cardiovasc Interv. 2010 May;3(5):515-23. doi: 10.1016/j.jcin.2010.02.009.
  • Kimokoti RW, Newby PK, Gona P, Zhu L, Jasuja GK, Pencina MJ, McKeon-O’Malley C, Fox CS, D’Agostino RB, Millen BE. Diet quality, physical activity, smoking status, and weight fluctuation are associated with weight change in women and men. J Nutr. 2010 Jul;140(7):1287-93. doi: 10.3945/jn.109.120808. Epub 2010 May 19.
  • Preis SR, Massaro JM, Hoffmann U, D’Agostino RB Sr, Levy D, Robins SJ, Meigs JB, Vasan RS, O’Donnell CJ, Fox CS. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab. 2010 Aug;95(8):3701-10. doi: 10.1210/jc.2009-1779. Epub 2010 May 19.
  • Malikova MA, Doros G, Joglar F, Rybin D, Petros JG, Farber A. A third-year surgery clerkship with extensive exposure to vascular surgery improves knowledge about vascular disease and the role of vascular surgeons in its management. Vasc Endovascular Surg. 2010 Jul;44(5):361-7. doi: 10.1177/1538574410362111. Epub 2010 May 18.
  • McCall WV, Blocker JN, D’Agostino R Jr, Kimball J, Boggs N, Lasater B, Rosenquist PB. Insomnia severity is an indicator of suicidal ideation during a depression clinical trial. Sleep Med. 2010 Oct;11(9):822-7. doi: 10.1016/j.sleep.2010.04.004. Epub 2010 May 15.
  • Bainey KR, Mehta SR. Aspirin for acute coronary syndromes: have we learned the correct dose yet?. Curr Cardiol Rep. 2010 Jul;12(4):344-7. doi: 10.1007/s11886-010-0120-y.
  • Bhardwaj A, Januzzi JL Jr. ST2: a novel biomarker for heart failure. Expert Rev Mol Diagn. 2010 May;10(4):459-64. doi: 10.1586/erm.10.25.
  • Yeh RW, Go AS. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med. 2010 May 10;170(9):759-64. doi: 10.1001/archinternmed.2010.88.
  • Liao SL, Elmariah S, van der Zee S, Sealove BA, Fuster V. Does medical therapy for thoracic aortic aneurysms really work? Are beta-blockers truly indicated? CON. Cardiol Clin. 2010 May;28(2):261-9. doi: 10.1016/j.ccl.2010.01.002.
  • Yoon JH, Yeh RW, Nam KH, Hoffman WD, Agnihotri AK, Jang IK. Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period. J Thromb Thrombolysis. 2010 Oct;30(3):276-80. doi: 10.1007/s11239-010-0485-1.
  • Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ; SPIRIT IV Investigators. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010 May 6;362(18):1663-74. doi: 10.1056/NEJMoa0910496.
  • Yeh DD, Lu JT, Kim A, Yeh RW, Scheinman MM. Calcium-triggered short-coupled polymorphous ventricular tachycardia. Pacing Clin Electrophysiol. 2010 Jan;33(1):117-22. doi: 10.1111/j.1540-8159.2009.02537.x.
  • Lp-PLA(2) Studies Collaboration, Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, Kaptoge S, Ballantyne C, Cannon CP, Criqui M, Cushman M, Hofman A, Packard C, Thompson SG, Collins R, Danesh J. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010 May 1;375(9725):1536-44. doi: 10.1016/S0140-6736(10)60319-4.
  • Sowden G, Mastromauro CA, Januzzi JL, Fricchione GL, Huffman JC. Detection of depression in cardiac inpatients: feasibility and results of systematic screening. Am Heart J. 2010 May;159(5):780-7. doi: 10.1016/j.ahj.2010.02.029.
  • Califf RM, Lokhnygina Y, Cannon CP, Stepanavage ME, McCabe CH, Musliner TA, Pasternak RC, Blazing MA, Giugliano RP, Harrington RA, Braunwald E. An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design. Am Heart J. 2010 May;159(5):705-9. doi: 10.1016/j.ahj.2010.03.004. Epub 2010 Mar 15.
  • Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KK, Klein LW, Krone RJ, Weintraub WS, Brindis RG, Rumsfeld JS, Spertus JA; NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010 May 4;55(18):1923-32. doi: 10.1016/j.jacc.2010.02.005.
  • Levy D, Splansky GL, Strand NK, Atwood LD, Benjamin EJ, Blease S, Cupples LA, D’Agostino RB Sr, Fox CS, Kelly-Hayes M, Koski G, Larson MG, Mutalik KM, Oberacker E, O’Donnell CJ, Sutherland P, Valentino M, Vasan RS, Wolf PA, Murabito JM. Consent for genetic research in the Framingham Heart Study. Am J Med Genet A. 2010 May;152A(5):1250-6. doi: 10.1002/ajmg.a.33377.
  • Shah RV, Januzzi JL Jr. ST2: a novel remodeling biomarker in acute and chronic heart failure. Curr Heart Fail Rep. 2010 Mar;7(1):9-14. doi: 10.1007/s11897-010-0005-9.
  • Elmariah S, Mohler ER 3rd. The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS. Curr Cardiol Rep. 2010 Mar;12(2):125-32. doi: 10.1007/s11886-010-0089-6.
  • Giugliano RP, Giraldez RR, Morrow DA, Antman EM, Gibson CM, Mohanavelu S, Murphy SA, McCabe CH, Braunwald E. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Eur Heart J. 2010 Sep;31(17):2103-10. doi: 10.1093/eurheartj/ehq100. Epub 2010 Apr 22.
  • Zimetbaum PJ, Thosani A, Yu HT, Xiong Y, Lin J, Kothawala P, Emons M. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?. Am J Med. 2010 May;123(5):446-53. doi: 10.1016/j.amjmed.2009.11.015.
  • Uchida T, Popma J, Stone GW, Ellis SG, Turco MA, Ormiston JA, Muramatsu T, Nakamura M, Nanto S, Yokoi H, Baim DS. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of “oculostenotic” reintervention in patients with intermediate lesions. JACC Cardiovasc Interv. 2010 Apr;3(4):403-11. doi: 10.1016/j.jcin.2010.01.010.
  • Husted S, Storey RF, Harrington RA, Emanuelsson H, Cannon CP. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel. Clin Cardiol. 2010 Apr;33(4):206-12. doi: 10.1002/clc.20732.
  • Krasnoff JB, Basaria S, Pencina MJ, Jasuja GK, Vasan RS, Ulloor J, Zhang A, Coviello A, Kelly-Hayes M, D’Agostino RB, Wolf PA, Bhasin S, Murabito JM. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab. 2010 Jun;95(6):2790-9. doi: 10.1210/jc.2009-2680. Epub 2010 Apr 9.
  • Naidu SS, Turco MA, Mauri L, Coolong A, Popma JJ, Kereiakes DJ. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). Am J Cardiol. 2010 Apr 15;105(8):1060-4. doi: 10.1016/j.amjcard.2009.12.004. Epub 2010 Feb 20.
  • Fredman L, Cauley JA, Hochberg M, Ensrud KE, Doros G; Study of Osteoporotic Fractures. Mortality associated with caregiving, general stress, and caregiving-related stress in elderly women: results of caregiver-study of osteoporotic fractures. J Am Geriatr Soc. 2010 May;58(5):937-43. doi: 10.1111/j.1532-5415.2010.02808.x. Epub 2010 Mar 30.
  • Baggish AL, van Kimmenade RR, Pinto Y, Richards AM, Lainchbury J, Bayes-Genis A, Santaló M, Ordonez-Llanos J, Januzzi JL. New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis. Biomarkers. 2010 Jun;15(4):307-14. doi: 10.3109/13547501003632580.
  • Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL Jr. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study. Am Heart J. 2010 Apr;159(4):532-538.e1. doi: 10.1016/j.ahj.2010.01.005.
  • Rohrbacker NJ, Kleinman NL, White SA, March JL, Reynolds MR. The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: associated costs, absences, and objective productivity loss. J Occup Environ Med. 2010 Apr;52(4):383-91. doi: 10.1097/JOM.0b013e3181d967bc.
  • Ray KK, Nazer B, Cairns R, Michael Gibson C, Cannon CP. Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes. J Thromb Thrombolysis. 2010 Jul;30(1):10-3. doi: 10.1007/s11239-010-0463-7.
  • Fredman L, Doros G, Cauley JA, Hillier TA, Hochberg MC. Caregiving, metabolic syndrome indicators, and 1-year decline in walking speed: results of Caregiver-SOF. J Gerontol A Biol Sci Med Sci. 2010 May;65(5):565-72. doi: 10.1093/gerona/glq025. Epub 2010 Mar 29.
  • Elmariah S, Goldberg LR, Allen MT, Kao A. The effects of race on peak oxygen consumption and survival in patients with systolic dysfunction. J Card Fail. 2010 Apr;16(4):332-9. doi: 10.1016/j.cardfail.2009.12.010. Epub 2010 Feb 9.
  • Lovely RS, Kazmierczak SC, Massaro JM, D’Agostino RB Sr, O’Donnell CJ, Farrell DH. Gamma’ fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clin Chem. 2010 May;56(5):781-8. doi: 10.1373/clinchem.2009.138347. Epub 2010 Mar 26.
  • Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, Meigs JB, Sutherland P, D’Agostino RB Sr, O’Donnell CJ, Fox CS. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring). 2010 Nov;18(11):2191-8. doi: 10.1038/oby.2010.59. Epub 2010 Mar 25.
  • Natarajan P, Ray KK, Cannon CP. High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol. 2010 Mar 30;55(13):1283-99. doi: 10.1016/j.jacc.2010.01.008.
  • Fujii A, Allen R, Doros G, O’Brien S. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome. J Perinatol. 2010 Oct;30(10):671-6. doi: 10.1038/jp.2010.21. Epub 2010 Mar 25.
  • Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J Perinatol. 2010 Oct;30(10):665-70. doi: 10.1038/jp.2010.20. Epub 2010 Mar 25.
  • Lasala JM, Mehran R, Moses JW, Popma JJ, Reiner JS, Sharma SK, Vetrovec GW. Evidence based management of patients undergoing PCI. Conclusion. Catheter Cardiovasc Interv. 2010 Mar 1;75 Suppl 1:S43-5. doi: 10.1002/ccd.22411.
  • Popma JJ, Nathan S, Hagberg RC, Khabbaz KR. Hybrid myocardial revascularization: an integrated approach to coronary revascularization. Catheter Cardiovasc Interv. 2010 Mar 1;75 Suppl 1:S28-34. doi: 10.1002/ccd.22402.
  • Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, Januzzi JL Jr. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail. 2010 May;3(3):354-61. doi: 10.1161/CIRCHEARTFAILURE.109.915280. Epub 2010 Mar 23.
  • Shah RV, Januzzi JL Jr. Images in cardiovascular medicine. ST-elevation alternans and nonsustained polymorphic ventricular tachycardia in a patient with Prinzmetal (variant) angina. Circulation. 2010 Mar 23;121(11):1371-3. doi: 10.1161/CIR.0b013e3181d8d759.
  • Speidl WS, Cimmino G, Ibanez B, Elmariah S, Hutter R, Garcia MJ, Fuster V, Goldman ME, Badimon JJ. Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model. Eur Heart J. 2010 Aug;31(16):2049-57. doi: 10.1093/eurheartj/ehq064. Epub 2010 Mar 19.
  • Newman AB, Walter S, Lunetta KL, Garcia ME, Slagboom PE, Christensen K, Arnold AM, Aspelund T, Aulchenko YS, Benjamin EJ, Christiansen L, D’Agostino RB Sr, Fitzpatrick AL, Franceschini N, Glazer NL, Gudnason V, Hofman A, Kaplan R, Karasik D, Kelly-Hayes M, Kiel DP, Launer LJ, Marciante KD, Massaro JM, Miljkovic I, Nalls MA, Hernandez D, Psaty BM, Rivadeneira F, Rotter J, Seshadri S, Smith AV, Taylor KD, Tiemeier H, Uh HW, Uitterlinden AG, Vaupel JW, Walston J, Westendorp RG, Harris TB, Lumley T, van Duijn CM, Murabito JM. A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci. 2010 May;65(5):478-87. doi: 10.1093/gerona/glq028. Epub 2010 Mar 18.
  • Hudson M, Greenbaum A, Brenton L, Gibson CM, Siegel R, Reeves LR, Sala MF, McKendall G, Bluguermann J, Echt D, Ohman EM, Weaver WD. Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial. JACC Cardiovasc Interv. 2010 Mar;3(3):352-9. doi: 10.1016/j.jcin.2009.11.020.
  • Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernández-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, Itescu S, Miller LW, Dinsmore JH, Dangas GD, Popma JJ, Hall JL, Holmes DR Jr; International Society for Cardiovascular Translational Research. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv. 2010 Mar;3(3):265-75. doi: 10.1016/j.jcin.2009.12.013.
  • van Kimmenade RR, Crijns HJ, Januzzi JL. Letter by van Kimmenade et al regarding article, “urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure”. Circulation. 2010 Mar 16;121(10):e242; author reply e243. doi: 10.1161/CIR.0b013e3181d78116.
  • Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, Kuntz RE, Cook EF, Mauri L. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation. 2010 Mar 30;121(12):1406-12. doi: 10.1161/CIRCULATIONAHA.109.895110. Epub 2010 Mar 15.
  • Friedrich TC, Piaskowski SM, León EJ, Furlott JR, Maness NJ, Weisgrau KL, Mac Nair CE, Weiler AM, Loffredo JT, Reynolds MR, Williams KY, Klimentidis YC, Wilson NA, Allison DB, Rakasz EG. High viremia is associated with high levels of in vivo major histocompatibility complex class I Downregulation in rhesus macaques infected with simian immunodeficiency virus SIVmac239. J Virol. 2010 May;84(10):5443-7. doi: 10.1128/JVI.02452-09. Epub 2010 Mar 10.
  • Krishnaswamy A, Lincoff AM, Cannon CP. The use and limitations of unfractionated heparin. Crit Pathw Cardiol. 2010 Mar;9(1):35-40. doi: 10.1097/HPC.0b013e3181d29713.
  • Cannon CP, Hoekstra JW, Larson DM, Carter RD, Cornish J, Karcher RB, Mencia WA, Berry CA, Stowell SA. Physician practice patterns in acute coronary syndromes: an initial report of an individual quality improvement program. Crit Pathw Cardiol. 2010 Mar;9(1):23-9. doi: 10.1097/HPC.0b013e3181d09d2d.
  • Mega S, Patti G, Cannon CP, Di Sciascio G. Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials. Crit Pathw Cardiol. 2010 Mar;9(1):19-22. doi: 10.1097/HPC.0b013e3181c9e719.
  • Gibler KB, Huskamp HA, Sabatine MS, Murphy SA, Cohen DJ, Cannon CP. Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction. Crit Pathw Cardiol. 2010 Mar;9(1):14-8. doi: 10.1097/HPC.0b013e3181c9e731.
  • Laskey W, Spence N, Zhao X, Mayo R, Taylor R, Cannon CP, Hernandez AF, Peterson ED, Fonarow GC. Regional differences in quality of care and outcomes for the treatment of acute coronary syndromes: an analysis from the get with the guidelines coronary artery disease program. Crit Pathw Cardiol. 2010 Mar;9(1):1-7. doi: 10.1097/HPC.0b013e3181cdb5a5.
  • De Luca G, Gibson CM, Gyöngyösi M, Zeymer U, Dudek D, Arntz HR, Bellandi F, Maioli M, Noc M, Zorman S, Gabriel HM, Emre A, Cutlip D, Rakowski T, Huber K, van’t Hof AW. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. J Thromb Thrombolysis. 2010 Oct;30(3):342-6. doi: 10.1007/s11239-010-0451-y.
  • Myla S, Bacharach JM, Ansel GM, Dippel EJ, McCormick DJ, Popma JJ. Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: the EPIC trial results. Catheter Cardiovasc Interv. 2010 May 1;75(6):817-22. doi: 10.1002/ccd.22386.
  • Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, van Es GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW; APPROACH Study Group. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation. 2010 Mar 16;121(10):1176-87. doi: 10.1161/CIRCULATIONAHA.109.881003. Epub 2010 Mar 1.
  • Januzzi JL Jr, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, Mohammed AA, Schlett CL, Nagurney JT, Hoffmann U, Koenig W. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation. 2010 Mar 16;121(10):1227-34. doi: 10.1161/CIRCULATIONAHA.109.893826. Epub 2010 Mar 1.
  • Baggish AL, Hutter AM Jr, Wang F, Yared K, Weiner RB, Kupperman E, Picard MH, Wood MJ. Cardiovascular screening in college athletes with and without electrocardiography: A cross-sectional study. Ann Intern Med. 2010 Mar 2;152(5):269-75. doi: 10.7326/0003-4819-152-5-201003020-00004.
  • Hopkins LN, Roubin GS, Chakhtoura EY, Gray WA, Ferguson RD, Katzen BT, Rosenfield K, Goldstein J, Cutlip DE, Morrish W, Lal BK, Sheffet AJ, Tom M, Hughes S, Voeks J, Kathir K, Meschia JF, Hobson RW 2nd, Brott TG. The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis. 2010 Mar;19(2):153-62. doi: 10.1016/j.jstrokecerebrovasdis.2010.01.001.
  • Truong QA, Siegel E, Karakas M, Januzzi JL Jr, Bamberg F, Mahabadi AA, Dasdemir S, Brady TJ, Bergmann A, Kunde J, Nagurney JT, Hoffmann U, Koenig W. Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial. Clin Chem. 2010 Apr;56(4):651-60. doi: 10.1373/clinchem.2009.138586. Epub 2010 Feb 25.
  • Acharjee S, Qin J, Murphy SA, McCabe C, Cannon CP. Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial). Am J Cardiol. 2010 Mar 1;105(5):619-23. doi: 10.1016/j.amjcard.2009.10.042.
  • Ducrocq G, Wallace JS, Baron G, Ravaud P, Alberts MJ, Wilson PW, Ohman EM, Brennan DM, D’Agostino RB, Bhatt DL, Steg PG; REACH Investigators. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J. 2010 May;31(10):1257-65. doi: 10.1093/eurheartj/ehq021. Epub 2010 Feb 24.
  • Cannon CP. Balancing the benefits of statins versus a new risk-diabetes. Lancet. 2010 Feb 27;375(9716):700-1. doi: 10.1016/S0140-6736(10)60234-6. Epub 2010 Feb 16.
  • Leon MB, Mauri L, Popma JJ, Cutlip DE, Nikolsky E, O’Shaughnessy C, Overlie PA, McLaurin BT, Solomon SL, Douglas JS Jr, Ball MW, Caputo RP, Jain A, Tolleson TR, Reen BM 3rd, Kirtane AJ, Fitzgerald PJ, Thompson K, Kandzari DE; ENDEAVOR IV Investigators. A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol. 2010 Feb 9;55(6):543-54. doi: 10.1016/j.jacc.2009.08.067.
  • Sakhuja R, Yeh RW, Bhatt DL. Antiplatelet agents in acute coronary syndromes. Curr Probl Cardiol. 2010 Mar;35(3):123-70. doi: 10.1016/j.cpcardiol.2009.11.002.
  • Cannon CP, Rhee KE, Califf RM, Boden WE, Hirsch AT, Alberts MJ, Cable G, Shao M, Ohman EM, Steg PG, Eagle KA, Bhatt DL; REACH Registry Investigators. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010 Feb 15;105(4):445-52. doi: 10.1016/j.amjcard.2009.10.014. Epub 2010 Jan 5.
  • Xian Y, Pan W, Peterson ED, Heidenreich PA, Cannon CP, Hernandez AF, Friedman B, Holloway RG, Fonarow GC; GWTG Steering Committee and Hospitals. Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals. Am Heart J. 2010 Feb;159(2):207-14. doi: 10.1016/j.ahj.2009.11.002.
  • Meredith IT, Worthley SG, Whitbourn R, Walters D, McClean D, Ormiston J, Horrigan M, Wilkins GT, Hendriks R, Matsis P, Muller D, Cutlip DE. Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial. EuroIntervention. 2010 Jan;5(6):692-7. doi: 10.4244/eijv5i6a114.
  • Vranckx P, Cutlip DE, Mehran R, Kint PP, Silber S, Windecker S, Serruys PW. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention. 2010 Feb;5(7):871-4. doi: 10.4244/eijv5i7a146.
  • Tung R, Josephson ME, Reddy V, Reynolds MR; SMASH-VT Investigators. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). J Cardiovasc Electrophysiol. 2010 Jul;21(7):799-803. doi: 10.1111/j.1540-8167.2009.01705.x. Epub 2010 Feb 1.
  • Gibson CM, Pride YB. Myocardial infarct size reduction with pexelizumab: the role of chance is patently clear. JACC Cardiovasc Imaging. 2010 Jan;3(1):61-3. doi: 10.1016/j.jcmg.2009.10.006.
  • Deibele AJ, Jennings LK, Tcheng JE, Neva C, Earhart AD, Gibson CM. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial. Circulation. 2010 Feb 16;121(6):784-91. doi: 10.1161/CIRCULATIONAHA.109.882746. Epub 2010 Feb 1.
  • Moore SA, Januzzi JL Jr. Found in translation soluble ST2 and heart disease. J Am Coll Cardiol. 2010 Jan 19;55(3):251-3. doi: 10.1016/j.jacc.2009.08.049.
  • Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010 Jan 27;303(4):333-40. doi: 10.1001/jama.2009.2029.
  • Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, Krantz MJ; Get With The Guidelines Steering Committee and Hospitals. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). Am J Cardiol. 2010 Jan 15;105(2):139-43. doi: 10.1016/j.amjcard.2009.09.003. Epub 2009 Nov 14.
  • Harkness JR, Sabatine MS, Braunwald E, Morrow DA, Sloan S, Wiviott SD, Giugliano RP, Antman EM, Cannon CP, Scirica BM. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction. Am Heart J. 2010 Jan;159(1):55-62. doi: 10.1016/j.ahj.2009.10.033.
  • Maree AO, Vangjeli C, Jneid H, Ryan J, Cox D, Cannon CP, Shields DC, Fitzgerald DJ. G-protein beta3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trial. J Thromb Haemost. 2010 May;8(5):934-41. doi: 10.1111/j.1538-7836.2010.03775.x. Epub 2010 Jan 22.
  • Liese AD, Nichols M, Hodo D, Mellen PB, Schulz M, Goff DC, D’Agostino RB. Food intake patterns associated with carotid artery atherosclerosis in the Insulin Resistance Atherosclerosis Study. Br J Nutr. 2010 May;103(10):1471-9. doi: 10.1017/S0007114509993369. Epub 2010 Jan 22.
  • Anderson HV, Rosenfield KA, White CJ, Ho KK, Spertus JA, Jones PG, Tang F, Cates CU, Jaff MR, Koroshetz WJ, Katzan IL, Hopkins LN, Rumsfeld JS, Brindis RG. Clinical features and outcomes of carotid artery stenting by clinical expert consensus criteria: a report from the CARE registry. Catheter Cardiovasc Interv. 2010 Mar 1;75(4):519-25. doi: 10.1002/ccd.22333.
  • Batista LM, Lima FO, Januzzi JL Jr, Donahue V, Snydeman C, Greer DM. Feasibility and safety of combined percutaneous coronary intervention and therapeutic hypothermia following cardiac arrest. Resuscitation. 2010 Apr;81(4):398-403. doi: 10.1016/j.resuscitation.2009.12.016. Epub 2010 Jan 18.
  • Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L; PLATelet inhibition and patient Outcomes Investigators. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet. 2010 Jan 23;375(9711):283-93. doi: 10.1016/S0140-6736(09)62191-7. Epub 2010 Jan 13.
  • Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD; Acute Coronary Treatment and Intervention Outcomes Network registry. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation. 2010 Jan 26;121(3):357-65. doi: 10.1161/CIRCULATIONAHA.109.865352. Epub 2010 Jan 11.
  • Sakhuja R, Mauri L. Controversies in the use of drug-eluting stents for acute myocardial infarction: a critical appraisal of the data. Annu Rev Med. 2010;61:215-31. doi: 10.1146/annurev.med.051508.221014.
  • Han Y, Chan J, Haber I, Peters DC, Zimetbaum PJ, Manning WJ, Yeon SB. Circumferential myocardial strain in cardiomyopathy with and without left bundle branch block. J Cardiovasc Magn Reson. 2010 Jan 5;12(1):2. doi: 10.1186/1532-429X-12-2.
  • Higashida RT, Popma JJ, Apruzzese P, Zimetbaum P; MAVErIC I and II Investigators. Evaluation of the medtronic exponent self-expanding carotid stent system with the medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II trials. Stroke. 2010 Feb;41(2):e102-9. doi: 10.1161/STROKEAHA.109.564161. Epub 2009 Dec 24.
  • Sofat R, Hingorani AD, Smeeth L, Humphries SE, Talmud PJ, Cooper J, Shah T, Sandhu MS, Ricketts SL, Boekholdt SM, Wareham N, Khaw KT, Kumari M, Kivimaki M, Marmot M, Asselbergs FW, van der Harst P, Dullaart RP, Navis G, van Veldhuisen DJ, Van Gilst WH, Thompson JF, McCaskie P, Palmer LJ, Arca M, Quagliarini F, Gaudio C, Cambien F, Nicaud V, Poirer O, Gudnason V, Isaacs A, Witteman JC, van Duijn CM, Pencina M, Vasan RS, D’Agostino RB Sr, Ordovas J, Li TY, Kakko S, Kauma H, Savolainen MJ, Kesäniemi YA, Sandhofer A, Paulweber B, Sorli JV, Goto A, Yokoyama S, Okumura K, Horne BD, Packard C, Freeman D, Ford I, Sattar N, McCormack V, Lawlor DA, Ebrahim S, Smith GD, Kastelein JJ, Deanfield J, Casas JP. Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation. 2010 Jan 5;121(1):52-62. doi: 10.1161/CIRCULATIONAHA.109.865444. Epub 2009 Dec 21.
  • van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi JL Jr. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail. 2010 Feb;12(2):129-36. doi: 10.1093/eurjhf/hfp179. Epub 2009 Dec 20.
  • Gibson CM, Hunter MS. Extraordinarily widespread and fantastically complex: comparative biology of endosymbiotic bacterial and fungal mutualists of insects. Ecol Lett. 2010 Feb;13(2):223-34. doi: 10.1111/j.1461-0248.2009.01416.x. Epub 2009 Dec 10.
  • Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis. Ann Hematol. 2010 Jun;89(6):579-84. doi: 10.1007/s00277-009-0874-8. Epub 2009 Dec 10.
  • Mohammed AA, Januzzi JL Jr. Clinical applications of highly sensitive troponin assays. Cardiol Rev. 2010 Jan-Feb;18(1):12-9. doi: 10.1097/CRD.0b013e3181c42f96.
  • Baggish AL, Yared K, Weiner RB, Wang F, Demes R, Picard MH, Hagerman F, Wood MJ. Differences in cardiac parameters among elite rowers and subelite rowers. Med Sci Sports Exerc. 2010 Jun;42(6):1215-20. doi: 10.1249/MSS.0b013e3181c81604.
  • Pinto DS. A 43-year-old man with angina, elevated troponin, and lateral ST depression: management of acute coronary syndromes. JAMA. 2010 Jan 6;303(1):54-63. doi: 10.1001/jama.2009.1870. Epub 2009 Dec 1.
  • Di Mundo R, Palumbo F, d’Agostino R. Influence of chemistry on wetting dynamics of nanotextured hydrophobic surfaces. Langmuir. 2010 Apr 6;26(7):5196-201. doi: 10.1021/la903654n.
  • D’Agostino R, Halpern NA. Acute care nurse practitioners in oncologic critical care: the memorial Sloan-Kettering cancer center experience. Crit Care Clin. 2010 Jan;26(1):207-17. doi: 10.1016/j.ccc.2009.09.003.
  • Semaan E, Hamburg N, Nasr W, Shaw P, Eberhardt R, Woodson J, Doros G, Rybin D, Farber A. Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty. Vasc Endovascular Surg. 2010 Jan;44(1):25-31. doi: 10.1177/1538574409345028. Epub 2009 Nov 25.
  • Wolongevicz DM, Zhu L, Pencina MJ, Kimokoti RW, Newby PK, D’Agostino RB, Millen BE. Diet quality and obesity in women: the Framingham Nutrition Studies. Br J Nutr. 2010 Apr;103(8):1223-9. doi: 10.1017/S0007114509992893. Epub 2009 Nov 24.
  • De Luca G, Gibson CM, Bellandi F, Noc M, Maioli M, Zorman S, Zeymer U, Gabriel HM, Emre A, Cutlip D, Arntz HR, Dudek D, Rakowski T, Gyongyosi M, Huber K, van’t Hof AW. Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. J Thromb Thrombolysis. 2010 Jul;30(1):23-8. doi: 10.1007/s11239-009-0419-y.
  • Martinez-Rumayor AA, Vazquez J, Rehman SU, Januzzi JL. Relative value of amino-terminal pro-B-type natriuretic peptide testing and radiographic standards for the diagnostic evaluation of heart failure in acutely dyspneic subjects. Biomarkers. 2010 Mar;15(2):175-82. doi: 10.3109/13547500903411087.
  • Chaosuwannakit N, D’Agostino R Jr, Hamilton CA, Lane KS, Ntim WO, Lawrence J, Melin SA, Ellis LR, Torti FM, Little WC, Hundley WG. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol. 2010 Jan 1;28(1):166-72. doi: 10.1200/JCO.2009.23.8527. Epub 2009 Nov 9.
  • Jensen JK, Ueland T, Atar D, Gullestad L, Mickley H, Aukrust P, Januzzi JL. Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. J Intern Med. 2010 Apr;267(4):410-7. doi: 10.1111/j.1365-2796.2009.02163.x. Epub 2009 Aug 26.
  • Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D’Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC, Bleecker ER; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010 Feb 15;181(4):315-23. doi: 10.1164/rccm.200906-0896OC. Epub 2009 Nov 5.
  • Hivert MF, Sullivan LM, Shrader P, Fox CS, Nathan DM, D’Agostino RB Sr, Wilson PW, Benjamin EJ, Meigs JB. The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism. 2010 Apr;59(4):540-6. doi: 10.1016/j.metabol.2009.08.017. Epub 2009 Oct 20.
  • McNamara P, Auerbach S, Johnson P, Harris E, Doros G. Impact of REM sleep on distortions of self-concept, mood and memory in depressed/anxious participants. J Affect Disord. 2010 May;122(3):198-207. doi: 10.1016/j.jad.2009.06.030. Epub 2009 Jul 24.
  • Haraldsdottir S, Gudnason T, Sigurdsson AF, Gudjonsdottir J, Lehman SJ, Eyjolfsson K, Scheving SS, Gibson CM, Hoffmann U, Jonsdottir B, Andersen K. Diagnostic accuracy of 64-slice multidetector CT for detection of in-stent restenosis in an unselected, consecutive patient population. Eur J Radiol. 2010 Nov;76(2):188-94. doi: 10.1016/j.ejrad.2009.05.030. Epub 2009 Jun 30.